Creation of a Longitudinal Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)


About this study

To develop a repository of blood, urine and tissue samples from patients with ILD to support future studies into the development of such biomarkers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with a diagnosis of ILD or any fibrotic disease of the lung
  • Patients willing to provide written informed consent

Exclusion Criteria:

  • Unwillingness/unable to give blood and urine samples

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eva Carmona Porquera, M.D., Ph.D.

Open for enrollment

Contact information:

Boleyn Andrist CCRP

(507) 284-9946

More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer